Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypes

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 4, 1997, Pages 485-489

  Chadwick, Ian G ^a   O'Toole, Laurence ^a   Morice, Alyn H ^a   Yeo, Wilfred W ^a   Jackson, Peter R ^a   Ramsay, Lawrence E ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

ACE gene polymorphism; Angiotensin I; Angiotensin converting enzyme

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN I; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; DRUG INFUSION; ENZYME ACTIVITY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HEART RATE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MALE; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRESSOR RESPONSE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ALDOSTERONE; ALLELES; ANGIOTENSIN I; ANGIOTENSIN II; BLOOD PRESSURE; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; OLIGOPEPTIDES; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RENIN; RENIN-ANGIOTENSIN SYSTEM; SODIUM; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0030996060     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199704000-00009     Document Type: Article

References (23)

1. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin-converting enzyme gene accounts for half the variance in serum enzyme levels. J Clin Invest 1990;86:1343-6.
2. Cambien F, Poirer O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
3. Tiret L, Kee F, Poirer O, et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993;341:991-2.
4. Raynolds MV, Bristow MR, Bush EW, et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or dilated cardiomyopathy. Lancet 1993;342:1073-5.
5. Schunkert H, Hense H, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-8.
6. Caldwell PRB, Seegal BC, Hsu KC, Das M, Soffer RL. Angiotensin-converting enzyme: vascular endothelial localisation. Science 1976;191:1050-1.
7. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T lymphocytes. Biochem J 1993;290:33-40.
8. Kaplan N, Silah J. A new approach to the differential diagnosis of renovascular hypertension. N Engl J Med 1964;271:536-41.
9. Belz GG, Essig J, Wellstein A. Haemodynamic responses to angiotensin I in normal volunteers and the antagonism by the ACE inhibitor cilazipril. J Cardiovasc Pharmacol 1987;9:219-24.
10. Essig J, Belz GG, Wellstein A. The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazipril, captopril and enalapril. Br J Clin Pharmacol 1989;27:217-23s.
11. Wellstein A, Essig J, Belz GG. A method for estimating the potency of angiotensin converting enzyme inhibitors in man. Br J Clin Pharmacol 1987;24:397-9.
12. Joubert PH, Brandt HD. Apparent racial differences in response to angiotensin I infusion. Eur J Clin Pharmacol 1990;39:183-5.
13. Ueda S, Elliott HL, Morton JJ, Connell JMC. Enhanced pressor response to angiotensin I in normotensive males with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995;25:1266-9.
14. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1; dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992;20:1433.
15. Holmquist B, Bunning P, Riordan JF. A continuous spectrophotometric assay for angiotensin converting enzyme. Analyt Biochem 1979;95:540.
16. Millar JA, Leckie BJ, Morton JJ, Jordan J, Tree M. Microassay for active and total renin in human plasma based on antibody trapping. Clin Chim Acta 1980;10:5-15.
17. Morton JJ, Webb DJ. Measurement of plasma angiotensin II. Clin Sci 1985;68:483-4.
18. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man: a quantitative method of assessing baroreflex sensitivity. Circ Res 1969;24:109-21.
19. Todd GP, Chadwick IG, Higgins KS, Yeo WW, Jackson PR, Ramsay LE. Relation between changes in blood pressure and serum ACE activity after a single dose of enalapril and ACE genotype in healthy subjects. Br J Clin Pharmacol 1995;39:131-4.
20. Danser AHJ, Konig MMG, Admiraal PJJ, Derkx FHN, Verdouw PD, Schalekamp MADH. Metabolism of angiotensin I by different tissues in the intact animal. Am J Physiol 1992;263:H418-28.
21. Samani NJ, Thompson JR, O'Toole L, Channer KS, Woods KL. A meta-analysis of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996;94: 708-12.
22. Lindpainter K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of the angiotensin-converting enzyme gene polymorphism and the risk of ischaemic heart disease. N Engl J Med 1995;332: 706-11.
23. Lindpainter K, Lee M, Larson MG, et al. Absence of association or genetic linkage between the angiotensin-converting enzyme gene polymorphism and left ventricular mass. N Engl J Med 1996; 334:1023-8.